Answers are grounded in this paper and cite their sources.
Overactive bladder syndrome is a prevalent condition with significant effects on quality of life. Non-invasive device–based neuromodulation offers an alternative to pharmacological and invasive treatments. This review examines the neurophysiological basis, clinical evidence and emerging technologies for non-invasive non-medical overactive bladder syndrome management. Transcutaneous tibial nerve stimulation has the most established evidence base, while newer wearable systems, including ZIDA, Vivally and TNS-01, facilitate home-based treatment. Peroneal neuromodulation is an expanding and promising modality of neuromodulation, with studies showing activation of supraspinal pathways in managing overactive bladder syndrome. Parasacral stimulation and extracorporeal magnetic stimulation provide alternative approaches. Although these technologies demonstrate promising efficacy and favourable safety profiles, heterogeneous protocols, limited comparative evidence and uncertain long-term durability necessitate further high-quality, independent studies. Level of Evidence: Not applicable.
No takes yet. Share an insight, caveat, or question.
Chang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: